Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
GLP-3RT is supplied as a lyophilized (freeze-dried) powder in a sterile glass vial sealed with a rubber stopper
2Check the research-use-only notice and pack information
Supports digestion, nutrient intake, energy, gut balance, and overall well-being while on GLP-1 medications
The winning approach isnt picking a drugits designing a system: start with orals where appropriate, reserve high-cost injectables for highest-risk members, and plan for step-up (and step-down) pathways as newer therapies emerge
Z.AgarwalM